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Background: Patients with diabetes have more extensive coronary atherosclerosis than those without diabetes. Achieving complete 
revascularization by coronary bypass surgery (CABG) or percutaneous coronary intervention (PCI) is challenging and may result in residual myocardial 
ischemia.
Methods: We examined 708 patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial who were randomized 
to prompt revascularization and who had not had a previous CABG or PCI. The patient’s revascularization procedure, CABG (N=267) or PCI (N=441), 
was determined by the patient’s physician before randomization. Myocardial jeopardy index (MJI), defined as the percentage of myocardial segments 
supplied by significantly diseased coronary arteries or their branches, was measured at baseline and immediately after CABG or PCI. The effect of 
post-procedure MJI (RMJI), on clinical outcomes was analyzed using a Cox proportional hazard analysis adjusted for gender, age, race, coronary 
artery disease risk factors, diabetes treatment randomization, revascularization strata, history of congestive heart failure, left ventricular function and 
diabetes duration. Mean follow-up duration was 5.3 years.
Results: Conclusions: Larger RMJI following coronary revascularization in patients with diabetes in the BARI 2D trial was associated with 
increased morbidity and mortality.
Results
Outcome event
RMJI Hazard Ratio (for a 10 point change in 
RMJI)
Nominal p-value
Death 1.13 0.0242
Cardiac Death 1.27 0.0075
Documented Myocardial Infarction 1.13 0.0843
Death/Myocardial Infarction/Stroke/
Subsequent Procedure
1.19 <.0001
